HPAPI
Scinopharm Taiwan to build injectable drug facility
July 3, 2012Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan
Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
